Lou Basenese, Director at ENDRA Life Sciences Inc. (NDRA), bought 10,000 shares at $0.82 ($8K) on 2020-05-26, disclosed to the SEC on 2020-05-27.
Open-market purchase of $8k NDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NDRA | BUY | 2020-05-29 | $9K | — | Filing → |
| NDRA | BUY | 2020-05-28 | $9K | — | Filing → |
| NDRA | BUY | 2020-05-22 | $7K | — | Filing → |